$1.10
-0.08-6.78%
Last update: Oct 30, 5:23 PM
HCW Biologics Inc
HCWBNASDAQ
HCW Biologics (HCWB) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-1.98 | $-2.64 | $-5.04 | $9.48 |
| Actual | $-11.58 | $2.22 | $-6.12 | $-12.12 |
| Surprise | -484.8% | +184.1% | -21.4% | -227.9% |
| Revenue | ||||
| Estimate | — | — | $7.0M | $7.0M |
| Actual | $135568 | $6.5M | $27010 | $15.6M |
| Surprise | — | — | -99.6% | +122.9% |
| Metric | Q3 '26E | Q4 '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-8.10 | $-8.34 |
| Revenue | ||
| Consensus | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 14, 2026 | $-11.58 | $-1.98 | -484.8 % |
| Q1 | May 14, 2026 | $2.22 | $-2.64 | 184.1 % |
| Q4 | Mar 31, 2026 | $-6.12 | $-5.04 | -21.4 % |
| Q3 | Nov 14, 2025 | $-12.12 | $9.48 | -227.9 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | Mar 31, 2026 | $27.01K | $7.00M | -99.6 % |
| Q3 | Nov 14, 2025 | $15.61M | $7.00M | 122.9 % |
| Q2 | Aug 18, 2025 | $6.55K | $7.00M | -99.9 % |
| Q4 | Apr 1, 2024 | $560.36K | $900.00K | -37.7 % |
